Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55,574,229
-
Total 13F shares
-
8,953,588
-
Share change
-
-413,905
-
Total reported value
-
$157,819,000
-
Price per share
-
$17.68
-
Number of holders
-
31
-
Value change
-
-$7,995,077
-
Number of buys
-
12
-
Number of sells
-
20
Institutional Holders of Ascendis Pharma A/S - ADR (ASND) as of Q2 2015
As of 30 Jun 2015,
Ascendis Pharma A/S - ADR (ASND) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,953,588 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, LLC, ORBIMED ADVISORS LLC, FMR LLC, RS INVESTMENT MANAGEMENT CO LLC, VHCP Management, LLC, Longwood Capital Partners LLC, GREAT POINT PARTNERS LLC, Visium Asset Management, LP, Rock Springs Capital Management LP, and Sectoral Asset Management Inc.
This page lists
31
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.